Skip to Content


In the US, Visipaque (iodixanol systemic) is a member of the drug class non-ionic iodinated contrast media and is used to treat Aortography, Cerebral Arteriography, Computed Tomography, Coronary Arteriography, Intra-arterial Digital Subtraction Angiography, Peripheral Arteriography, Renal Arteriography, Urography and Venography.

US matches:

Ingredient matches for Visipaque


Iodixanol is reported as an ingredient of Visipaque in the following countries:

  • Argentina
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Bulgaria
  • Chile
  • Croatia (Hrvatska)
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Israel
  • Japan
  • Latvia
  • Lithuania
  • Malta
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Poland
  • Romania
  • Serbia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Tunisia
  • Turkey


Trometamol is reported as an ingredient of Visipaque in the following countries:

  • Norway

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.